Therapeutic potential of mesenchymal stem cells for diabetes

Alvaro Moreira, Samuel Kahlenberg, Peter Hornsby

Research output: Contribution to journalReview articlepeer-review

44 Scopus citations


Mesenchymal stem cells (MSCs) are self-renewing multipotent cells that have the capacity to secrete multiple biologic factors that can restore and repair injured tissues. Preclinical and clinical evidence have substantiated the therapeutic benefit of MSCs in various medical conditions. Currently, MSCs are the most commonly used cell-based therapy in clinical trials because of their regenerative effects, ease of isolation and low immunogenicity. Experimental and clinical studies have provided promising results using MSCs to treat diabetes. This review will summarize the role of MSCs on tissue repair, provide emerging strategies to improve MSC function and describe how these processes translate to clinical treatments for diabetes.

Original languageEnglish (US)
Pages (from-to)R109-R120
JournalJournal of Molecular Endocrinology
Issue number3
StatePublished - Oct 2017


  • Diabetes
  • Endocrine
  • Mesenchymal stem cell
  • Tissue regeneration

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology


Dive into the research topics of 'Therapeutic potential of mesenchymal stem cells for diabetes'. Together they form a unique fingerprint.

Cite this